Health & Fitness · Eritrea · Good news
Eritrea beats trachoma, the world's leading infectious cause of blindness, after two decades of work
The World Health Organization has validated Eritrea's elimination of trachoma as a public health problem, making it the 11th country in WHO's African Region to reach the milestone.

Eritrea has eliminated trachoma as a public health problem, the World Health Organization said this week, after a two-decade campaign against the bacterial eye infection that is the world's leading infectious cause of blindness.
WHO validated the achievement on the recommendation of an independent review group that examined the evidence Eritrea submitted. The country is the 11th in WHO's African Region and the 34th in the world to reach the milestone. It is also the 23rd country in the region to have eliminated at least one neglected tropical disease.
"After two decades of determined effort, Eritrea has consigned trachoma as a public health problem to history," said WHO Director-General Dr Tedros Adhanom Ghebreyesus. "This is a victory for the communities most affected by this devastating disease."
How it was done
Trachoma spreads through contact with eye and nasal discharge, and thrives where clean water and sanitation are scarce. Repeated infections scar the inside of the eyelid until the lashes turn inward and scrape the eye, which can end in blindness.
Many Eritreans live in remote rural areas where health care, water and sanitation are hard to reach. After baseline surveys carried out between 2006 and 2020, the country rolled out WHO's four-part strategy in the communities that needed it: surgery for the advanced, in-turned eyelash stage of the disease, antibiotics to clear infection, face washing to cut transmission, and better access to water and sanitation.
Health workers surveyed all 58 of the country's sub-zobas, its second-level administrative areas, and used digital tools to map affected communities and send resources to hard-to-reach places. Most of the antibiotic used was oral azithromycin donated by Pfizer through the International Trachoma Initiative. WHO said a community-led sanitation approach delivered large gains with limited outside funding.
"This success belongs first and foremost to the people of Eritrea," said Dr Mary Stephen, WHO's representative in the country. She credited communities, the Ministry of Health, the Fred Hollows Foundation, partners and health workers.
Still work to do elsewhere
Eritrea will keep watching for new cases of the in-turned eyelash stage and treating them after validation. Globally, the number of people needing interventions against trachoma fell by about 94%, from an estimated 1.5 billion in 2002 to under 100 million by November 2025, WHO says. As of March 2026, 92 million people still lived in areas where the disease is endemic, and trachoma remained a public health problem in at least part of 29 countries.
SourcesShow
- World Health Organization, "Eritrea eliminates trachoma: a major public health milestone", news release, 16 Nov 2026. https://www.who.int/news/item/16-11-2026-eritrea-eliminates-trachoma-a-major-public-health-milestone
- WHO Africa ESPEN, "Eritrea validated for eliminating trachoma as a public health problem", Nov 2026. https://espen.afro.who.int/updates-events/updates/eritrea-validated-eliminating-trachoma-public-health-problem
- African Leaders Malaria Alliance, "ALMA congratulates the State of Eritrea on eliminating trachoma as a public health problem", Nov 2026. https://alma2030.org/news/alma-congratulates-the-state-of-eritrea-on-eliminating-trachoma-as-a-public-health-problem/
AB24 · Nairobi

